##gff-version 3
##sequence-region Q02078 1 507
Q02078	UniProtKB	Chain	1	507	.	.	.	ID=PRO_0000199428;Note=Myocyte-specific enhancer factor 2A	
Q02078	UniProtKB	Domain	3	57	.	.	.	Note=MADS-box;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00251	
Q02078	UniProtKB	DNA binding	58	86	.	.	.	Note=Mef2-type;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q02078	UniProtKB	Region	266	283	.	.	.	Note=Required for interaction with MAPKs	
Q02078	UniProtKB	Region	289	296	.	.	.	Note=Beta domain	
Q02078	UniProtKB	Compositional bias	4	31	.	.	.	Note=Lys-rich (basic)	
Q02078	UniProtKB	Compositional bias	141	186	.	.	.	Note=Ser/Thr-rich	
Q02078	UniProtKB	Compositional bias	420	446	.	.	.	Note=Gln/Pro-rich	
Q02078	UniProtKB	Site	176	177	.	.	.	Note=Cleavage;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02078	UniProtKB	Site	213	214	.	.	.	Note=Cleavage;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02078	UniProtKB	Site	466	467	.	.	.	Note=Cleavage;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02078	UniProtKB	Modified residue	59	59	.	.	.	Note=Phosphoserine%3B by CK2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q02078	UniProtKB	Modified residue	98	98	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q02078	UniProtKB	Modified residue	235	235	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q02078	UniProtKB	Modified residue	249	249	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19608861;Dbxref=PMID:19608861	
Q02078	UniProtKB	Modified residue	255	255	.	.	.	Note=Phosphoserine%3B by MAPK14;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:12586839;Dbxref=PMID:18669648,PMID:23186163,PMID:12586839	
Q02078	UniProtKB	Modified residue	312	312	.	.	.	Note=Phosphothreonine%3B by MAPK7 and MAPK14;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10330143,ECO:0000269|PubMed:10849446,ECO:0000269|PubMed:12586839,ECO:0000269|PubMed:17785444,ECO:0000269|PubMed:9858528;Dbxref=PMID:10330143,PMID:10849446,PMID:12586839,PMID:17785444,PMID:9858528	
Q02078	UniProtKB	Modified residue	312	312	.	.	.	Note=Phosphothreonine%3B by NLK;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10330143,ECO:0000269|PubMed:10849446,ECO:0000269|PubMed:12586839,ECO:0000269|PubMed:17785444,ECO:0000269|PubMed:9858528;Dbxref=PMID:10330143,PMID:10849446,PMID:12586839,PMID:17785444,PMID:9858528	
Q02078	UniProtKB	Modified residue	319	319	.	.	.	Note=Phosphothreonine%3B by MAPK7 and MAPK14;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10330143,ECO:0000269|PubMed:10849446,ECO:0000269|PubMed:12586839,ECO:0000269|PubMed:9858528;Dbxref=PMID:10330143,PMID:10849446,PMID:12586839,PMID:9858528	
Q02078	UniProtKB	Modified residue	355	355	.	.	.	Note=Phosphoserine%3B by MAPK7;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10849446;Dbxref=PMID:10849446	
Q02078	UniProtKB	Modified residue	403	403	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q2MJT0	
Q02078	UniProtKB	Modified residue	408	408	.	.	.	Note=Phosphoserine%3B by CDK5;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12586839,ECO:0000269|PubMed:12691662,ECO:0000269|PubMed:16371476,ECO:0000269|PubMed:16484498;Dbxref=PMID:12586839,PMID:12691662,PMID:16371476,PMID:16484498	
Q02078	UniProtKB	Modified residue	415	415	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q60929	
Q02078	UniProtKB	Modified residue	453	453	.	.	.	Note=Phosphoserine%3B by MAPK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9858528;Dbxref=PMID:9858528	
Q02078	UniProtKB	Cross-link	403	403	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate	
Q02078	UniProtKB	Alternative sequence	19	86	.	.	.	ID=VSP_043338;Note=In isoform 7. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q02078	UniProtKB	Alternative sequence	19	62	.	.	.	ID=VSP_046018;Note=In isoform 8. VTFTKRKFGLMKKAYELSVLCDCEIALIIFNSSNKLFQYASTDM->TLRKKGLNGCESPDADDYFEHSPLSEDRFSKLNEDSDFIFKRGP;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q02078	UniProtKB	Alternative sequence	63	132	.	.	.	ID=VSP_046019;Note=In isoform 8. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q02078	UniProtKB	Alternative sequence	87	132	.	.	.	ID=VSP_006240;Note=In isoform MEFA%2C isoform RSRFC9%2C isoform 6 and isoform 7. ALNKKEHRGCDSPDPDTSYVLTPHTEEKYKKINEEFDNMMRNHKIA->TLRKKGLNGCESPDADDYFEHSPLSEDRFSKLNEDSDFIFKRGP;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:1516833,ECO:0000303|PubMed:1748287,ECO:0000303|Ref.2,ECO:0000303|Ref.6;Dbxref=PMID:14702039,PMID:1516833,PMID:1748287	
Q02078	UniProtKB	Alternative sequence	289	296	.	.	.	ID=VSP_006241;Note=In isoform RSRFC4%2C isoform RSRFC9%2C isoform 5%2C isoform 6 and isoform 8. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:1516833,ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:1748287,ECO:0000303|Ref.2,ECO:0000303|Ref.6;Dbxref=PMID:1516833,PMID:15489334,PMID:1748287	
Q02078	UniProtKB	Alternative sequence	420	421	.	.	.	ID=VSP_006242;Note=In isoform RSRFC4 and isoform RSRFC9. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:1516833,ECO:0000303|PubMed:1748287,ECO:0000303|Ref.2;Dbxref=PMID:1516833,PMID:1748287	
Q02078	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_038407;Note=N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15496429;Dbxref=dbSNP:rs121918530,PMID:15496429	
Q02078	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_038408;Note=P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15496429,ECO:0000269|PubMed:15958500,ECO:0000269|PubMed:18086930;Dbxref=dbSNP:rs121918529,PMID:15496429,PMID:15958500,PMID:18086930	
Q02078	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_038409;Note=G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15496429;Dbxref=PMID:15496429	
Q02078	UniProtKB	Natural variant	440	446	.	.	.	ID=VAR_017743;Note=Loss of nuclear localization%3B 66%25 decrease in transcription activation%3B loss of synergistic activation by MEF2A and GATA1 through a dominant-negative mechanism. Missing	
Q02078	UniProtKB	Mutagenesis	176	176	.	.	.	Note=Abolishes cleavage at sites 1 and 2 by caspase 3. Increased cleavage at site 3 by caspase 3. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11904443;Dbxref=PMID:11904443	
Q02078	UniProtKB	Mutagenesis	213	213	.	.	.	Note=Abolishes cleavage at sites 2 and 3 by caspase 7. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11904443;Dbxref=PMID:11904443	
Q02078	UniProtKB	Mutagenesis	255	255	.	.	.	Note=Slightly increased MEF2A protein level. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12586839;Dbxref=PMID:12586839	
Q02078	UniProtKB	Mutagenesis	255	255	.	.	.	Note=Decreased MEF2A protein level. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12586839;Dbxref=PMID:12586839	
Q02078	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Reduced p38 alpha- and beta2-mediated transcriptional activity%3B when associated with A-270. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10330143;Dbxref=PMID:10330143	
Q02078	UniProtKB	Mutagenesis	270	270	.	.	.	Note=Reduced p38 alpha- and beta2-mediated transcriptional activity%3B when associated with A-269. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10330143;Dbxref=PMID:10330143	
Q02078	UniProtKB	Mutagenesis	273	273	.	.	.	Note=Reduced p38 alpha- and beta2-mediated transcriptional activity%3B when associated with A-275. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10330143;Dbxref=PMID:10330143	
Q02078	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Reduced p38 alpha- and beta2-mediated transcriptional activity%3B when associated with A-273. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10330143;Dbxref=PMID:10330143	
Q02078	UniProtKB	Mutagenesis	277	277	.	.	.	Note=Reduced p38 alpha- and beta2-mediated transcriptional activity%3B when associated with A-278. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10330143;Dbxref=PMID:10330143	
Q02078	UniProtKB	Mutagenesis	278	278	.	.	.	Note=Reduced p38 alpha- and beta2-mediated transcriptional activity%3B when associated with A-277. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10330143;Dbxref=PMID:10330143	
Q02078	UniProtKB	Mutagenesis	312	312	.	.	.	Note=Greatly reduced p38-mediated phosphorylation. Abolishes p38-mediated transcriptional activation%3B when associated with A-319. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10849446,ECO:0000269|PubMed:9858528;Dbxref=PMID:10849446,PMID:9858528	
Q02078	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Greatly reduced p38-mediated phosphorylation. Abolishes P38-mediated transcriptional activation%3B when associated with A-312. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10849446,ECO:0000269|PubMed:9858528;Dbxref=PMID:10849446,PMID:9858528	
Q02078	UniProtKB	Mutagenesis	355	355	.	.	.	Note=No effect on p38-mediated transcriptional activity. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10849446,ECO:0000269|PubMed:9858528;Dbxref=PMID:10849446,PMID:9858528	
Q02078	UniProtKB	Mutagenesis	387	387	.	.	.	Note=No effect on p38-mediated phosphorylation. S->A	
Q02078	UniProtKB	Mutagenesis	403	403	.	.	.	Note=Abolishes sumoylation. No change in subcellular location nor in DNA binding. Loss of transcriptional repression. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16371476,ECO:0000269|PubMed:16563226;Dbxref=PMID:16371476,PMID:16563226	
Q02078	UniProtKB	Mutagenesis	408	408	.	.	.	Note=Loss of sumoylation. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12691662,ECO:0000269|PubMed:16371476;Dbxref=PMID:12691662,PMID:16371476	
Q02078	UniProtKB	Mutagenesis	408	408	.	.	.	Note=Rescues sumoylation. S->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12691662,ECO:0000269|PubMed:16371476;Dbxref=PMID:12691662,PMID:16371476	
Q02078	UniProtKB	Mutagenesis	453	453	.	.	.	Note=No effect on p38-mediated phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9858528;Dbxref=PMID:9858528	
Q02078	UniProtKB	Mutagenesis	479	479	.	.	.	Note=No effect on p38-mediated phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9858528;Dbxref=PMID:9858528	
Q02078	UniProtKB	Sequence conflict	430	430	.	.	.	Note=Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02078	UniProtKB	Sequence conflict	430	430	.	.	.	Note=Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q02078	UniProtKB	Helix	14	38	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1EGW	
Q02078	UniProtKB	Beta strand	42	48	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1EGW	
Q02078	UniProtKB	Turn	50	52	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1C7U	
Q02078	UniProtKB	Beta strand	54	60	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1EGW	
Q02078	UniProtKB	Helix	62	71	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1EGW	
Q02078	UniProtKB	Beta strand	77	80	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3KOV	
Q02078	UniProtKB	Helix	81	90	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3P57	
